Table 1.
1AD-fused protein | 2BD-T975–1053 | Number of colonies assessed | Number of colonies surviving on DDO/X/A | 3P value in the chi-square test |
---|---|---|---|---|
ARP7 | + | 34 | 32 | < 10−10 |
− | 31 | 2 | ||
MED37F | + | 34 | 2 | 0.888 |
− | 39 | 2 | ||
PDI | + | 30 | 6 | 0.958 |
− | 39 | 8 | ||
HDT2 | + | 30 | 4 | 0.816 |
− | 35 | 4 | ||
RPS14A | + | 38 | 5 | 0.78 |
− | 39 | 6 | ||
HisH3.3 | + | 33 | 2 | 0.949 |
− | 31 | 2 | ||
HisH2AXa | + | 33 | 3 | 0.187 |
− | 34 | 7 | ||
HisH2B.11 | + | 31 | 5 | 0.42 |
− | 33 | 8 | ||
HAP1 | + | 33 | 2 | 0.348 |
− | 31 | 4 | ||
MYB3 | + | 35 | 31 | 0.00178 |
− | 33 | 18 | ||
BIM1 | + | 38 | 20 | < 10−4 |
− | 34 | 2 | ||
SINAT1 | + | 34 | 33 | < 10−10 |
− | 31 | 3 |
AD: GAL4 activation domain.
BD: GAL4 DNA-binding domain. The presence of BD-fused T-975–1053 and its absence are indicated as + and −, respectively.
The chi-square test was performed for each AD-fused protein to examine whether the presence of BD-T975–1053 is independent of the percentages of the colonies that could survive on DDO/X/A.